C20orf141

Across TCGA pan-cancer cohorts, C20orf141 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated C20orf141 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher C20orf141 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated C20orf141 expression acts as an unfavorable survival marker.

STAD, LUAD, and COAD are the cancer types where C20orf141 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	II,III,IV	0.183	0.677	.004	24	view →
LUAD	OS	Median	All	0.090	0.812	<.001	24	view →
COAD	OS	Median	All	0.159	0.799	.002	21	view →
LIHC	DFS	Median	All	0.044	0.553	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

C20orf141–STAD (OS)

Open the STAD breakdown →